Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINDER2: Fulvestrant dose comparison in advanced breast cancer
NCT00313170Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- May 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of fulvestrant in breast cancer, sponsored by AstraZeneca. Started May 2006; status: completed.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00313170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313170.